ENDRA Life Sciences (NDRA) Gains from Sales and Divestitures (2021)
ENDRA Life Sciences (NDRA) posted quarterly Gains from Sales and Divestitures of $3.9 million for Q4 2021.
ENDRA Life Sciences (NDRA) Gains from Sales and Divestitures (2021) Analysis & Trends
ENDRA Life Sciences has disclosed Gains from Sales and Divestitures across 1 years of filings, most recently posting $3.9 million for Q4 2021.
- In Q4 2021, Gains from Sales and Divestitures changed N/A year-over-year to $3.9 million; the TTM figure through Dec 2021 stood at $3.9 million (changed N/A YoY), while the FY2021 annual figure was $3.9 million, changed N/A from the prior year.
- Gains from Sales and Divestitures steadied at $3.9 million in Q4 2021.
- Over the last five years, Gains from Sales and Divestitures for NDRA reached as high as $3.9 million in Q4 2021 and fell as low as $3.9 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 3.92 Mn |
| Dec 31, 2021 | 3.92 Mn |